Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Reducing unnecessary biopsies while detecting significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.

Benson MC, Zappala S.

Urol Oncol. 2019 Jun;37(6):348. doi: 10.1016/j.urolonc.2019.01.022. Epub 2019 Feb 6. No abstract available.

PMID:
30737156
2.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.

Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM.

Cell. 2018 Apr 5;173(2):515-528.e17. doi: 10.1016/j.cell.2018.03.017.

3.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.

J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13. Review.

4.

Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance.

Whalen MJ, Pak JS, Lascano D, Ahlborn D, Matulay JT, McKiernan JM, Benson MC, Wenske S.

Clin Genitourin Cancer. 2018 Apr;16(2):e425-e435. doi: 10.1016/j.clgc.2017.10.007. Epub 2017 Oct 16.

PMID:
29113772
5.

Preoperative Antibiotics Before Bladder Biopsy: Are They Necessary?

Lipsky MJ, Sayegh C, Theofanides MC, Benson MC, Cooper KL.

Urology. 2017 Dec;110:121-126. doi: 10.1016/j.urology.2017.06.058. Epub 2017 Aug 31.

PMID:
28864339
6.

A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy.

Deibert CM, Silva MV, RoyChoudhury A, McKiernan JM, Scherr DS, Seres D, Benson MC.

Urology. 2016 Oct;96:69-73. doi: 10.1016/j.urology.2016.06.045. Epub 2016 Jul 8.

PMID:
27402372
7.

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.

Motamedinia P, Scott AN, Bate KL, Sadeghi N, Salazar G, Shapiro E, Ahn J, Lipsky M, Lin J, Hruby GW, Badani KK, Petrylak DP, Benson MC, Donovan MJ, Comper WD, McKiernan JM, Russo LM.

PLoS One. 2016 May 4;11(5):e0154507. doi: 10.1371/journal.pone.0154507. eCollection 2016.

8.

Editorial Comment.

Benson MC.

Urology. 2016 Apr;90:147. doi: 10.1016/j.urology.2015.11.065. No abstract available.

PMID:
27036684
9.

The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis.

Haas CR, Barlow LJ, Badalato GM, DeCastro GJ, Benson MC, McKiernan JM.

J Urol. 2016 Jun;195(6):1704-9. doi: 10.1016/j.juro.2016.01.087. Epub 2016 Jan 22.

PMID:
26807928
10.

Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy.

Pagano MJ, Whalen MJ, Paulucci DJ, Reddy BN, Matulay JT, Rothberg M, Scarberry K, Patel T, Shapiro EY, RoyChoudhury A, McKiernan J, Benson MC, Badani KK.

Prostate. 2016 Feb;76(2):226-34. doi: 10.1002/pros.23114. Epub 2015 Oct 20.

PMID:
26481325
11.

Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools.

Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, RoyChoudhury A, Bivalacqua TJ, DeCastro GJ, Benson MC, McKiernan JM.

Urol Oncol. 2015 Oct;33(10):426.e1-12. doi: 10.1016/j.urolonc.2015.06.002. Epub 2015 Jul 9.

12.

Predicting Renal Parenchymal Loss after Nephron Sparing Surgery.

Meyer A, Woldu SL, Weinberg AC, Thoreson GR, Pierorazio P, Matulay JT, Benson MC, DeCastro GJ, McKiernan JM.

J Urol. 2015 Sep;194(3):658-63. doi: 10.1016/j.juro.2015.03.098. Epub 2015 Mar 25.

PMID:
25818030
13.

Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes.

Berg WT, Danzig MR, Pak JS, Korets R, RoyChoudhury A, Hruby G, Benson MC, McKiernan JM, Badani KK.

Prostate. 2015 Jul 1;75(10):1085-91. doi: 10.1002/pros.22992. Epub 2015 Mar 21.

PMID:
25809289
14.

ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer.

Gaya JM, López-Martínez JM, Karni-Schmidt O, Bonal DM, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C, Castillo-Martin M.

J Urol. 2015 Apr;193(4):1144-50. doi: 10.1016/j.juro.2014.10.098. Epub 2014 Oct 28.

PMID:
25444981
15.

Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.

Perez TY, Danzig MR, Ghandour RA, Badani KK, Benson MC, McKiernan JM.

Urology. 2015 Jan;85(1):85-9. doi: 10.1016/j.urology.2014.07.072. Epub 2014 Nov 11.

PMID:
25440819
16.

Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.

Danzig MR, Kotamarti S, Ghandour RA, Rothberg MB, Dubow BP, Benson MC, Badani KK, McKiernan JM.

Prostate Cancer Prostatic Dis. 2015 Mar;18(1):63-8. doi: 10.1038/pcan.2014.47. Epub 2014 Nov 18.

PMID:
25403419
17.

Who really benefits from nephron-sparing surgery?

Woldu SL, Weinberg AC, Korets R, Ghandour R, Danzig MR, RoyChoudhury A, Kalloo SD, Benson MC, DeCastro GJ, McKiernan JM.

Urology. 2014 Oct;84(4):860-7. doi: 10.1016/j.urology.2014.05.061.

PMID:
25260447
18.

Single luminal epithelial progenitors can generate prostate organoids in culture.

Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, Bergren SK, Badani KK, McKiernan JM, Benson MC, Hibshoosh H, Shen MM.

Nat Cell Biol. 2014 Oct;16(10):951-61, 1-4. doi: 10.1038/ncb3047. Epub 2014 Sep 21.

19.

Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome.

Schubert T, Danzig MR, Kotamarti S, Ghandour RA, Lascano D, Dubow BP, Decastro GJ, Benson MC, McKiernan JM.

World J Urol. 2015 Jun;33(6):847-52. doi: 10.1007/s00345-014-1383-5. Epub 2014 Aug 23.

PMID:
25149472
20.

Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer.

Stevenson SM, Danzig MR, Ghandour RA, Deibert CM, Decastro GJ, Benson MC, McKiernan JM.

Urol Oncol. 2014 Nov;32(8):1172-7. doi: 10.1016/j.urolonc.2014.05.001. Epub 2014 Jul 4.

PMID:
24998787
21.

Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure.

McKiernan JM, Holder DD, Ghandour RA, Barlow LJ, Ahn JJ, Kates M, Badalato GM, Roychoudhury A, Decastro GJ, Benson MC.

J Urol. 2014 Dec;192(6):1633-8. doi: 10.1016/j.juro.2014.06.084. Epub 2014 Jul 1.

PMID:
24996128
22.

The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer.

Lin J, Deibert CM, Holder D, Benson MC, McKiernan JM.

Can J Urol. 2014 Feb;21(1):7108-13.

PMID:
24529010
23.

Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer.

Spencer BA, Shim JJ, Hershman DL, Zacharia BE, Lim EA, Benson MC, Neugut AI.

Support Care Cancer. 2014 Jun;22(6):1549-55. doi: 10.1007/s00520-013-2112-0. Epub 2014 Jan 16.

PMID:
24429841
24.

Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins.

Shapiro EY, Scarberry K, Patel T, Bergman A, Ahn JJ, Sahi N, RoyChoudhury A, Deutch I, McKiernan JM, Benson MC, Badani KK.

J Endourol. 2014 Feb;28(2):208-13. doi: 10.1089/end.2013.0393. Epub 2013 Nov 9.

PMID:
24044423
25.

A molecular signature predictive of indolent prostate cancer.

Irshad S, Bansal M, Castillo-Martin M, Zheng T, Aytes A, Wenske S, Le Magnen C, Guarnieri P, Sumazin P, Benson MC, Shen MM, Califano A, Abate-Shen C.

Sci Transl Med. 2013 Sep 11;5(202):202ra122. doi: 10.1126/scitranslmed.3006408. Erratum in: Sci Transl Med. 2013 Sep 18;5(203):203er9.

26.

Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer.

Spencer BA, McBride RB, Hershman DL, Buono D, Herr HW, Benson MC, Gupta-Mohile S, Neugut AI.

J Oncol Pract. 2013 Mar;9(2):92-8. doi: 10.1200/JOP.2011.000480. Epub 2012 Oct 30.

27.

Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury.

Wenske S, Olsson CA, Benson MC.

Urology. 2013 Jul;82(1):231-6. doi: 10.1016/j.urology.2013.02.046. Epub 2013 May 2.

PMID:
23642933
28.

Findings of routine apical margin biopsy during robot-assisted radical prostatectomy.

Wambi CO, Patel T, Shapiro EY, Tal O, Hruby GW, Berg WT, Benson MC, Badani KK.

J Laparoendosc Adv Surg Tech A. 2013 Jun;23(6):511-5. doi: 10.1089/lap.2012.0417. Epub 2013 Apr 27.

PMID:
23621833
29.

Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer.

Barlow LJ, Benson MC.

Curr Urol Rep. 2013 Apr;14(2):65-70. doi: 10.1007/s11934-013-0312-2. Review.

PMID:
23378162
30.

Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer.

Spencer BA, Insel BJ, Hershman DL, Benson MC, Neugut AI.

Support Care Cancer. 2013 May;21(5):1303-11. doi: 10.1007/s00520-012-1666-6. Epub 2013 Jan 6.

PMID:
23292697
31.

Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapy.

Barlow LJ, McKiernan JM, Benson MC.

J Urol. 2013 Mar;189(3):834-9. doi: 10.1016/j.juro.2012.10.068. Epub 2012 Oct 30.

PMID:
23123371
32.

Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance.

Motamedinia P, RiChard JL, McKiernan JM, DeCastro GJ, Benson MC.

Urology. 2012 Nov;80(5):1070-4. doi: 10.1016/j.urology.2012.07.049.

PMID:
23107398
33.

Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.

Ritch CR, Morrison BF, Hruby G, Coard KC, Mayhew R, Aiken W, Benson MC, McKiernan JM.

BJU Int. 2013 Apr;111(4 Pt B):E186-90. doi: 10.1111/j.1464-410X.2012.11540.x. Epub 2012 Oct 26.

34.

Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression.

RiChard JL, Motamedinia P, McKiernan JM, DeCastro GJ, Benson MC.

J Urol. 2012 Dec;188(6):2177-80. doi: 10.1016/j.juro.2012.08.011. Epub 2012 Oct 18.

PMID:
23083872
35.

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak DP, Benson MC, Silva JM, Cordon-Cardo C.

Cancer Cell. 2012 Sep 11;22(3):373-88. doi: 10.1016/j.ccr.2012.07.016.

36.

Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.

Shapiro EY, Lipsky MJ, Cha DY, McKiernan JM, Benson MC, Gupta M.

J Endourol. 2012 Dec;26(12):1645-50. doi: 10.1089/end.2012.0229. Epub 2012 Oct 9.

PMID:
22834939
37.

The first assistant sparing technique robot-assisted partial nephrectomy decreases warm ischemia time while maintaining good perioperative outcomes.

Berg WT, Rich CR, Badalato GM, Deibert CM, Wambi CO, Landman J, Benson MC, Badani KK.

J Endourol. 2012 Nov;26(11):1448-53. doi: 10.1089/end.2012.0129. Epub 2012 Oct 9.

PMID:
22691152
38.

Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?

Badalato GM, Gaya JM, Hruby G, Patel T, Kates M, Sadeghi N, Benson MC, McKiernan JM.

BJU Int. 2012 Nov;110(10):1471-7. doi: 10.1111/j.1464-410X.2012.11116.x. Epub 2012 Apr 4.

39.

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer.

Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM.

Prostate. 2012 Sep 15;72(13):1469-77. doi: 10.1002/pros.22499. Epub 2012 Feb 1.

40.

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.

Yeshchina O, Badalato GM, Wosnitzer MS, Hruby G, RoyChoudhury A, Benson MC, Petrylak DP, McKiernan JM.

Urology. 2012 Feb;79(2):384-90. doi: 10.1016/j.urology.2011.10.050. Epub 2011 Dec 22.

PMID:
22196406
41.

Chemically directed assembly of photoactive metal oxide nanoparticle heterojunctions via the copper-catalyzed azide-alkyne cycloaddition "click" reaction.

Cardiel AC, Benson MC, Bishop LM, Louis KM, Yeager JC, Tan Y, Hamers RJ.

ACS Nano. 2012 Jan 24;6(1):310-8. doi: 10.1021/nn203585r. Epub 2012 Jan 10.

PMID:
22196212
42.

A citric acid-derived ligand for modular functionalization of metal oxide surfaces via "click" chemistry.

Bishop LM, Yeager JC, Chen X, Wheeler JN, Torelli MD, Benson MC, Burke SD, Pedersen JA, Hamers RJ.

Langmuir. 2012 Jan 17;28(2):1322-9. doi: 10.1021/la204145t. Epub 2011 Dec 28.

PMID:
22145802
43.

Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis.

Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM.

BJU Int. 2012 Jul;110(2):211-6. doi: 10.1111/j.1464-410X.2011.10666.x. Epub 2011 Nov 16.

44.

Validating the use of the Mimic dV-trainer for robotic surgery skill acquisition among urology residents.

Korets R, Mues AC, Graversen JA, Gupta M, Benson MC, Cooper KL, Landman J, Badani KK.

Urology. 2011 Dec;78(6):1326-30. doi: 10.1016/j.urology.2011.07.1426. Epub 2011 Oct 15.

PMID:
22001096
45.

Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy.

Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylack DP, Benson MC, McKiernan JM, Cordon-Cardo C.

J Urol. 2011 Nov;186(5):2094-100. doi: 10.1016/j.juro.2011.06.051. Epub 2011 Sep 23.

PMID:
21944130
46.

DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.

Delgado-Cruzata L, Hruby GW, Gonzalez K, McKiernan J, Benson MC, Santella RM, Shen J.

DNA Cell Biol. 2012 Feb;31(2):187-92. doi: 10.1089/dna.2011.1311. Epub 2011 Aug 10.

47.

Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomy.

Truesdale MD, Polland AR, Graversen JA, Sartori S, Hruby GW, Landman J, McKiernan JM, Benson MC, Badani KK.

J Endourol. 2011 Sep;25(9):1427-33. doi: 10.1089/end.2010.0688. Epub 2011 Jul 28.

PMID:
21797762
48.

Modular "click" chemistry for electrochemically and photoelectrochemically active molecular interfaces to tin oxide surfaces.

Benson MC, Ruther RE, Gerken JB, Rigsby ML, Bishop LM, Tan Y, Stahl SS, Hamers RJ.

ACS Appl Mater Interfaces. 2011 Aug;3(8):3110-9. doi: 10.1021/am200615r. Epub 2011 Jul 29.

PMID:
21766849
49.

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.

Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM.

Cancer. 2012 Jan 15;118(2):358-64. doi: 10.1002/cncr.26278. Epub 2011 Jun 29.

50.

Comparison of distal ureteral management strategies during laparoscopic nephroureterectomy.

Ritch CR, Kearns JT, Mues AC, Hruby GW, Benson MC, McKiernan JM, Landman J.

J Endourol. 2011 Jul;25(7):1149-54. doi: 10.1089/end.2010.0542. Epub 2011 Jun 20.

PMID:
21689004

Supplemental Content

Loading ...
Support Center